0001225208-24-005331.txt : 20240429
0001225208-24-005331.hdr.sgml : 20240429
20240429170600
ACCESSION NUMBER: 0001225208-24-005331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240425
FILED AS OF DATE: 20240429
DATE AS OF CHANGE: 20240429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McClellan Mark B.
CENTRAL INDEX KEY: 0001567006
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24892431
MAIL ADDRESS:
STREET 1: THE BROOKINGS INSITUTION
STREET 2: 1775 MASSACHUSETTS AVE., NW
CITY: WASHINGTON
STATE: DC
ZIP: 20036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-04-25
0000200406
JOHNSON & JOHNSON
JNJ
0001567006
McClellan Mark B.
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
0
Deferred Share Units
2024-04-25
4
A
0
1385.6970
0.0000
A
Common Stock
1385.6970
17867.7150
D
Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
/s/ Raavi K. Deol, as attorney-in-fact for Mark B. McClellan
2024-04-29